INDO US BIO-TECH | SHEEL INTERN. | INDO US BIO-TECH/ SHEEL INTERN. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 26.4 | 160.4% | View Chart |
P/BV | x | 8.6 | 3.4 | 257.4% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH SHEEL INTERN. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
SHEEL INTERN. Mar-23 |
INDO US BIO-TECH/ SHEEL INTERN. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 19 | 661.8% | |
Low | Rs | 25 | 7 | 372.6% | |
Sales per share (Unadj.) | Rs | 61.6 | 0.1 | 41,501.3% | |
Earnings per share (Unadj.) | Rs | 7.2 | 3.3 | 218.1% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 3.3 | 241.3% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 4.0 | 1,353.3% | |
Shares outstanding (eoy) | m | 10.03 | 6.00 | 167.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 86.7 | 1.4% | |
Avg P/E ratio | x | 10.4 | 3.9 | 268.9% | |
P/CF ratio (eoy) | x | 9.4 | 3.8 | 243.1% | |
Price / Book Value ratio | x | 1.4 | 3.2 | 43.3% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 77 | 980.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 3 | 399.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 1 | 69,376.4% | |
Other income | Rs m | 0 | 30 | 0.7% | |
Total revenues | Rs m | 618 | 31 | 2,008.7% | |
Gross profit | Rs m | 94 | -10 | -951.7% | |
Depreciation | Rs m | 8 | 0 | 5,900.0% | |
Interest | Rs m | 12 | 0 | 120,100.0% | |
Profit before tax | Rs m | 74 | 20 | 372.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 0 | -7,300.0% | |
Profit after tax | Rs m | 72 | 20 | 364.6% | |
Gross profit margin | % | 15.2 | -1,109.2 | -1.4% | |
Effective tax rate | % | 2.0 | -0.1 | -2,103.5% | |
Net profit margin | % | 11.7 | 2,231.2 | 0.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 8 | 7,098.2% | |
Current liabilities | Rs m | 123 | 1 | 12,417.2% | |
Net working cap to sales | % | 77.1 | 837.0 | 9.2% | |
Current ratio | x | 4.9 | 8.5 | 57.2% | |
Inventory Days | Days | 1 | 5,565 | 0.0% | |
Debtors Days | Days | 146,261,410 | 1,296,161,343 | 11.3% | |
Net fixed assets | Rs m | 90 | 18 | 487.3% | |
Share capital | Rs m | 100 | 60 | 167.2% | |
"Free" reserves | Rs m | 445 | -36 | -1,240.1% | |
Net worth | Rs m | 545 | 24 | 2,262.2% | |
Long term debt | Rs m | 17 | 0 | - | |
Total assets | Rs m | 689 | 27 | 2,565.4% | |
Interest coverage | x | 7.2 | 1,985.0 | 0.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0 | 2,704.3% | |
Return on assets | % | 12.3 | 74.0 | 16.6% | |
Return on equity | % | 13.3 | 82.4 | 16.1% | |
Return on capital | % | 15.3 | 82.4 | 18.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 8 | 64.5% | |
From Investments | Rs m | -67 | -13 | 532.2% | |
From Financial Activity | Rs m | 63 | 4 | 1,568.3% | |
Net Cashflow | Rs m | 1 | 0 | -381.1% |
Indian Promoters | % | 70.2 | 39.4 | 178.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 60.6 | 49.2% | |
Shareholders | 1,166 | 19,628 | 5.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | SHEEL INT. |
---|---|---|
1-Day | 8.77% | 2.20% |
1-Month | 26.17% | -4.39% |
1-Year | 113.64% | 19.47% |
3-Year CAGR | 152.58% | 87.44% |
5-Year CAGR | 42.16% | 26.30% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the SHEEL INT. share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of SHEEL INT. the stake stands at 39.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of SHEEL INT..
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
SHEEL INT. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of SHEEL INT..
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.